Other
2030
Biogen 2030 increased by 12.1% to $650.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.3%, from $665.00M to $650.00M. Over 3 years (FY 2020 to FY 2023), 2030 shows an upward trend with a 28.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
A stable or declining schedule of amortization supports long-term margin expansion.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2030. It provides a m...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_4a0a03Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $220.00M | $195.00M | $195.00M | $180.00M | $180.00M | $175.00M | $175.00M | $170.00M | $170.00M | $435.00M | $480.00M | $710.00M | $710.00M | $615.00M | $665.00M | $665.00M | $580.00M | $650.00M |
| QoQ Change | — | -11.4% | +0.0% | -7.7% | +0.0% | -2.8% | +0.0% | -2.9% | +0.0% | +155.9% | +10.3% | +47.9% | +0.0% | -13.4% | +8.1% | +0.0% | -12.8% | +12.1% |
| YoY Change | — | — | — | — | -18.2% | -10.3% | -10.3% | -5.6% | -5.6% | +148.6% | +174.3% | +317.6% | +317.6% | +41.4% | -6.3% | -6.3% | -5.7% | -2.3% |
Range$170.00M – $710.00M
CAGR+29.0%
Avg YoY Growth+66.4%
Median YoY Growth-5.6%
2030 at Other Companies
Frequently Asked Questions
- What is Biogen's 2030?
- Biogen (BIIB) reported 2030 of $650.00M in Q1 2026.
- How has Biogen's 2030 changed year-over-year?
- Biogen's 2030 decreased by 2.3% year-over-year, from $665.00M to $650.00M.
- What is the long-term trend for Biogen's 2030?
- Over 3 years (2020 to 2023), Biogen's 2030 has grown at a 28.7% compound annual growth rate (CAGR), from $225.00M to $480.00M.
- What does 2030 mean?
- The expected non-cash expense for acquired intangible assets in the year 2030.